Search research articles
Contact Us
Filters
Showing results (21-30 of 45) with videos related to
Page
of 5
Sort By:
Human Pathology
|
December 21, 2013
African Americans with oropharyngeal carcinoma have significantly poorer outcomes despite similar rates of human papillomavirus-mediated carcinogenesis
Tatyana Isayeva, Jie Xu, Qian Dai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 28, 2009
NCCN Task Force Report: Management of dermatologic and other toxicities associated with EGFR inhibition in patients with cancer
Barbara Burtness, Milan Anadkat, Surendra Basti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 21, 2016
Association of human papillomavirus and p16 status with mucositis and dysphagia for head and neck cancer patients treated with radiotherapy with or without cetuximab: Assessment from a phase 3 registration trial
James A Bonner, Jordi Giralt, Paul M Harari, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 25, 2010
Integrating epidermal growth factor receptor assay with clinical parameters improves risk classification for relapse and survival in head-and-neck squamous cell carcinoma
Christine H Chung, Qiang Zhang, Elizabeth M Hammond, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 2, 2011
Glioma-associated oncogene family zinc finger 1 expression and metastasis in patients with head and neck squamous cell carcinoma treated with radiation therapy (RTOG 9003)
Christine H Chung, James J Dignam, M Elizabeth Hammond, et al.
Head & Neck
|
August 23, 2019
Changing functional status within 6 months posttreatment is prognostic of overall survival in patients with head and neck cancer: NRG Oncology Study
Ronald C Eldridge, Stephanie L Pugh, Andy Trotti, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 26, 2026
Randomized, double-blind, sham-controlled trial of an intraoral photobiomodulation device for oral mucositis and associated complications due to radiotherapy for head and neck cancer
Kenneth Hu, Pratish Shah, M Connie Nguyen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 3, 2020
Location as Destiny: Identifying Geospatial Disparities in Radiation Treatment Interruption by Neighborhood, Race, and Insurance
Daniel V Wakefield, Matthew Carnell, Austin P H Dove, et al.
Practical Radiation Oncology
|
July 30, 2024
Radiation Therapy for HPV-Positive Oropharyngeal Squamous Cell Carcinoma: An ASTRO Clinical Practice Guideline
Danielle N Margalit, Christopher J Anker, Michalis Aristophanous, et al.
Cancer
|
March 27, 2019
Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trials
Carole Fakhry, Qiang Zhang, Maura L Gillison, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 45) with videos related to
Sort By:
Page
of 5
Human Pathology
|
December 21, 2013
African Americans with oropharyngeal carcinoma have significantly poorer outcomes despite similar rates of human papillomavirus-mediated carcinogenesis
Tatyana Isayeva, Jie Xu, Qian Dai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 28, 2009
NCCN Task Force Report: Management of dermatologic and other toxicities associated with EGFR inhibition in patients with cancer
Barbara Burtness, Milan Anadkat, Surendra Basti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 21, 2016
Association of human papillomavirus and p16 status with mucositis and dysphagia for head and neck cancer patients treated with radiotherapy with or without cetuximab: Assessment from a phase 3 registration trial
James A Bonner, Jordi Giralt, Paul M Harari, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 25, 2010
Integrating epidermal growth factor receptor assay with clinical parameters improves risk classification for relapse and survival in head-and-neck squamous cell carcinoma
Christine H Chung, Qiang Zhang, Elizabeth M Hammond, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 2, 2011
Glioma-associated oncogene family zinc finger 1 expression and metastasis in patients with head and neck squamous cell carcinoma treated with radiation therapy (RTOG 9003)
Christine H Chung, James J Dignam, M Elizabeth Hammond, et al.
Head & Neck
|
August 23, 2019
Changing functional status within 6 months posttreatment is prognostic of overall survival in patients with head and neck cancer: NRG Oncology Study
Ronald C Eldridge, Stephanie L Pugh, Andy Trotti, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 26, 2026
Randomized, double-blind, sham-controlled trial of an intraoral photobiomodulation device for oral mucositis and associated complications due to radiotherapy for head and neck cancer
Kenneth Hu, Pratish Shah, M Connie Nguyen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 3, 2020
Location as Destiny: Identifying Geospatial Disparities in Radiation Treatment Interruption by Neighborhood, Race, and Insurance
Daniel V Wakefield, Matthew Carnell, Austin P H Dove, et al.
Practical Radiation Oncology
|
July 30, 2024
Radiation Therapy for HPV-Positive Oropharyngeal Squamous Cell Carcinoma: An ASTRO Clinical Practice Guideline
Danielle N Margalit, Christopher J Anker, Michalis Aristophanous, et al.
Cancer
|
March 27, 2019
Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trials
Carole Fakhry, Qiang Zhang, Maura L Gillison, et al.
Page
of 5